Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OMEGA: a prospective, randomised, double-blind, placebo-controlled multicentre study in patients who survived acute myocardial infarction to investigate the efficacy and safety of 1 gram omega-3-fatty acid ethyl esters (omega-3FAE) daily versus placebo to reduce the risk of sudden cardiac death

Next Previous
X
Search
Trial Profile

OMEGA: a prospective, randomised, double-blind, placebo-controlled multicentre study in patients who survived acute myocardial infarction to investigate the efficacy and safety of 1 gram omega-3-fatty acid ethyl esters (omega-3FAE) daily versus placebo to reduce the risk of sudden cardiac death

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Sep 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Myocardial infarction; Sudden death
  • Focus Therapeutic Use
  • Acronyms OMEGA

    • Most Recent Events

    • 30 Mar 2009 Results reported at the 58th Annual Scientific Session of the American College of Cardiology (ACC 2009), as reported by Pronova BioPharma.
    • 30 Mar 2009 Results were presented as a late-breaking clinical trial during the 58th Annual Scientific Session of the American College of Cardiology (ACC 2009).
    • 26 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top